newsfilter
← Earnings
Earnings Releases·

Haemonetics — Second Quarter Fiscal 2027 Earnings Summary

Haemonetics Corporation reported second-quarter fiscal 2027 revenue of $357.8 million, representing a 9.3% increase year-over-year, with organic revenue growth of 10.0%. The company achieved adjusted earnings per diluted share of $1.35 and generated $103.8 million in free cash flow for the quarter. Reflecting strong momentum, Haemonetics updated its full-year fiscal 2027 guidance to project reported revenue growth of 8% to 11% and organic revenue growth of 6% to 9%.

Company
HAEMONETICS CORP
Sector
Healthcare
Industry
Medical Instruments & Supplies